Trial Profile
Open-label single-arm phase 2 study of ALIMTA [pemetrexed] in patients with advanced non-small cell lung cancer who have had prior chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2006
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 27 Jul 2006 Status change
- 07 Nov 2005 New trial record.